Business - CNBC

1. Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

2. UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months

3. IMAX CEO expects $1.2 billion in box office receipts this year, the best in the company's history

4. Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

5. Yankees throw out one of baseball's most notorious traditions: Players can now grow beards

6. The family-office gold rush is spurring a conference craze — with one notable comeback

7. Home sales drop sharply as prices hit an all-time high for January

8. Rivian beats Wall Street's fourth-quarter expectations, but expects lower deliveries in 2025

9. Trump is 'not happy' with Boeing over Air Force One delays, but airlines are growing upbeat

10. Walmart shares drop as retailer says profit growth will slow

11. ESPN plans to add user-generated content to upcoming 'flagship' streaming service

12. Amazon to gain creative control of James Bond franchise from Broccoli family

13. Hasbro says it's taking steps to offset China tariff effects

14. From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs

15. Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall 

16. Walmart is getting a bump from a surprising cohort: Wealthier shoppers

17. UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say

18. Forever 21 is in talks with liquidators, indicating it's struggling to find a buyer

19. San Francisco 49ers explore 10% minority stake sale at about $9 billion valuation

20. Carvana expects another 'strong' year after topping fourth-quarter expectations